MBIO earnings date and last-quarter result: next report 2026-08-18, last quarter beat, P/E -1.41. Updated 2026-07-23.
Mustang Bio (MBIO) Research Hub
Mustang Bio (MBIO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.3601 USD (-2.68%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.41, market cap 0.00B. This hub links to the full technical, earnings and options research available for MBIO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.3601 USD (-2.68%) |
| 52-week range | 0.36 USD – 0.7698 USD |
| Trend regime | Range |
| 14-day RSI | 21.9 (Oversold) |
| Trailing P/E | -1.41 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-18 |
Available research for MBIO
Covered Call on MBIO: how it works, illustrative setup around the real 0.3601 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MBIO: how it works, illustrative setup around the real 0.3601 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MBIO: how it works, illustrative setup around the real 0.3601 USD price, max profit/loss, breakeven and when to use it. Educational.
MBIO technical analysis: range, last 0.3601 USD, RSI 21.9, 52w range 0.36 USD–0.7698 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MBIO in?
Mustang Bio (MBIO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MBIO in an uptrend or downtrend?
As of 2026-10-26, MBIO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MBIO's trailing P/E ratio?
MBIO's trailing P/E is -1.41, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does MBIO next report earnings?
MBIO is next scheduled to report earnings on 2026-08-18.